Accure Therapeutics
SpainEntry
2025
Hold
1yr
Status
Active
Who owns Accure Therapeutics?
Accure Therapeutics is currently owned by Asabys Partners through Sabadell Asabys Health Innovation Investments (2019 vintage), since 2025. Across its history, Accure Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-09
Most recent investor
Asabys PartnersSabadell Asabys Health Innovation Investments · 2019 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQSpain
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2020 · present
Alta Life SciencesActive
2020 · present(6yr) · Alta Life Sciences Spain I FCR · 2016 · Life Sciences VC
Asabys PartnersActive
2025 · present(1yr) · Sabadell Asabys Health Innovation Investments · 2019 · Life Sciences VC
More from Sabadell Asabys Health Innovation Investments
Other portfolio companies in the same fund.
United States
BelgiumMore PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack Accure Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Accure Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue